Under copyright Constraint(s) on Use: This work is protected by the U.S. Copyright Law (Title 17, U.S.C.). Use of this work beyond that allowed by "fair use" or any license applied to this work requires written permission of the copyright holder(s). Responsibility for obtaining permissions and any use and distribution of this work rests exclusively with the user and not the UC San Diego Library. Inquiries can be made to the UC San Diego Library program having custody of the work. Use: This work is available from the UC San Diego Library. This digital copy of the work is intended to support research, teaching, and private study.
Rights Holder and Contact
UC Regents
Description
Around the world, at least 53 COVID-19 vaccines are currently undergoing clinical trials. Four of the largest and most promising have reached the final Phase III stage. UC San Diego is a testing site for three of the big four: Moderna, AstraZeneca and Janssen/Johnson & Johnson. In this episode, we speak with Susan Little, MD, principal investigator for two COVID-19 clinical trials in San Diego that are focused on finding a vaccine for SARS-CoV-2. Dr. Little discusses the science behind vaccines, how they will work to address the current pandemic, and when a potential COVID-19 vaccine will be ready. Born digital Special Collections & Archives, UC San Diego, La Jolla, 92093-0175 (https://lib.ucsd.edu/sca) [Title, Date]. N Equals One. Special Collections & Archives, UC San Diego. [Digital Object URL] Episode 43
Type
sound
Identifier
ark:/20775/bb42789326
Language
English
Subject
Clinical trials Vaccines Podcast COVID-19 University of California, San Diego
If you're wondering about permissions and what you can do with this item, a good starting point is the "rights information" on this page. See our terms of use for more tips.
Share your story
Has Calisphere helped you advance your research, complete a project, or find something meaningful? We'd love to hear about it; please send us a message.
